TopoTarget A/S  

(Public, CPH:TOPO)   Watch this stock  
Find more results for TOPO
+0.10 (2.67%)
Jul 11 - Close
CPH real-time data - Disclaimer
Currency in DKK
Range 3.73 - 3.85
52 week 2.10 - 4.45
Open 3.75
Vol / Avg. 207,334.00/824,334.00
Mkt cap 561.30M
P/E     -
Div/yield     -
EPS -0.25
Shares 145.79M
Beta     -
Inst. own     -
Apr 24, 2014
Topotarget A/S Annual Shareholder Meeting

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -1971.65% -419.38%
Operating margin -2145.88% -409.55%
EBITD margin - -387.23%
Return on average assets -11.40% -12.85%
Return on average equity -12.43% -14.15%
Employees 13 -
CDP Score - -


Fruebjergvej 3
+45-39-178392 (Phone)
+45-39-179492 (Fax)

Website links


Topotarget A/S is a Denmark-based biopharmaceutical company focused on the field of oncology. The Company is engaged in the development of cancer therapies, focusing primarily on the development of its principal drug candidate, Belinostat. Belinostat can be used in combination with full doses of chemotherapy, and is in a pivotal trial within peripheral T-cell lymphoma (PTCL) and phase II in cancer of unknown primary (CUP). It works in partnerships with Spectrum Pharmaceuticals Inc., Multimeric Biotherapeutics Inc. and the National Cancer Institute. As of December 31, 2011, the Company had five wholly owned subsidiaries, namely Topotarget UK Limited, Topotarget Germany AG, Topotarget USA Inc., Topotarget Switzerland S.A. and Topotarget Netherlands B.V. The Company�s two largest shareholders are HealthCap funds and Avanza bank. In April 2014, combined holdings of Topotarget A/S shares for all relevant HealthCap entities (HealthCap III and HealthCap IV) were reduced below 10%.

Officers and directors

Bo Jesper Hansen M.D., Ph.D. Executive Independent Chairman of the Board
Age: 56
Anders Fink Vadsholt Chief Executive Officer
Age: 44
Lone Dahl Director of Finance
Age: 53
Elisabeth V. Carstensen Ph.D. Director of Pharmaceutical Operations
Age: 44
Anne V. Sillemann Director of Global Regulatory Affairs
Age: 48
Jette Tjoernelund Director of Science
Age: 50
Per Samuelsson Non-Independent Director
Age: 52
Jeffrey H. Buchalter MBA Independent Director
Age: 57
Anker Lundemose M.D., Ph.D. Independent Director
Age: 51
Ingelise Saunders Independent Director
Age: 65